;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Siga, U.S. Department of Health and Human Services infectious news

    Siga Technologies Inc. (NASDAQ:SIGA), New York, N.Y. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Siga filed for Chapter 11 bankruptcy U.S. Bankruptcy Court for the Southern …

    Published on 9/22/2014
  • Takeda pharmaceuticals news

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka Japan Business: Pharmaceuticals Takeda announced the reorganization of its commercial and R&D operations -- its first major organizational move since naming Christophe …

    Published on 9/22/2014
  • AbbVie, Besins Healthcare, Teva, U.S. Federal Trade Commission generics, endocrine/metabolic news

    AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Besins Healthcare S.A., Bangkok, Thailand Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel U.S. Federal Trade Commission, Washington, D.C. Business: Generics, …

    Published on 9/15/2014
  • AstraZeneca, Teva inflammation, pulmonary news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Inflammation, Pulmonary The U.K. High Court ruled that AstraZeneca's European Patent No. 1…

    Published on 9/15/2014
  • AstraZeneca, U.S. Department of Justice cardiovascular news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. U.S. Department of Justice, Washington, D.C. Business: Cardiovascular AstraZeneca said the DoJ closed its investigation into the Phase III PLATO trial, which supported …

    Published on 9/15/2014
  • Bavarian Nordic, U.S. Department of Health and Human Services infectious news

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Bavarian Nordic said HHS's Biomedical Advanced Research and Development Authority (…

    Published on 9/15/2014
  • Bill & Melinda Gates Foundation infectious news

    Bill & Melinda Gates Foundation, Seattle, Wash. Business: Infectious The Bill & Melinda Gates Foundation committed $50 million to support emergency efforts -- including the purchase of essential medical supplies and …

    Published on 9/15/2014
  • Boehringer Ingelheim pharmaceuticals news

    Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Pharmaceuticals Boehringer said it will restructure to reduce costs by 15% in Germany. In Germany, Boehringer's headcount increased to 14,087 in June 2014 from 13,…

    Published on 9/15/2014
  • Cytori, U.S. Department of Health and Human Services gene/cell therapy, other news

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Gene/Cell therapy, Other HHS's Biomedical Advanced Research and Development …

    Published on 9/15/2014
  • Depomed neurology news

    Depomed Inc. (NASDAQ:DEPO), Menlo Park, Calif. Business: Neurology Depomed said a judge in the U.S. Federal District Court for the District of Columbia ruled that FDA is required to grant Orphan Drug exclusivity to …

    Published on 9/15/2014
  • Hospira, Food and Drug Administration neurology news

    Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Food and Drug Administration, Silver Spring, Md. Business: Neurology The U.S. District Court for the District of Maryland sided with FDA in a suit challenging whether the …

    Published on 9/15/2014
  • Liquidia, Lq3 dental, drug delivery news

    Liquidia Technologies Inc., Research Triangle Park, N.C. Lq3 Pharmaceuticals Inc., Morrisville, N.C. Business: Dental, Drug delivery Liquidia spun out Lq3 to develop therapies for oral health conditions using Liquidia's…

    Published on 9/15/2014
  • Merck KGaA, Pfizer, Accelerated Cure Project autoimmune news

    Merck KGaA (Xetra:MRK), Darmstadt, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Accelerated Cure Project (ACP) for Multiple Sclerosis, Waltham, Mass. Business: Autoimmune Merck's EMD Serono Inc. biopharmaceutical …

    Published on 9/15/2014
  • MMRGlobal infectious, antibodies news

    MMRGlobal Inc. (OTCQB:MMRF), Los Angeles, Calif. Business: Infectious, Antibodies MMRGlobal said it plans on granting royalty-free licenses to universities interested in using the company's antibody technology for R&D …

    Published on 9/15/2014
  • Nanosphere diagnostic news

    Nanosphere Inc. (NASDAQ:NSPH), Northbrook, Ill. Business: Diagnostic Molecular Diagnostics company Nanosphere hired Jefferies as a financial advisor to assist in developing and evaluating strategic alternatives. The …

    Published on 9/15/2014
  • Zephyrus, University of California proteomics, supply/service news

    Zephyrus Biosciences Inc., Berkeley, Calif. University of California, Berkeley, Calif. Business: Proteomics, Supply/Service The university spun off Zephyrus with an exclusive license to develop and commercialize …

    Published on 9/15/2014
  • Biocartis, Pronota diagnostic news

    Biocartis S.A., Lausanne, Switzerland Pronota N.V., Zwijnaarde, Belgium Business: Diagnostic Biocartis spun out newco MyCartis (Lausanne, Switzerland), a combination of Pronota and Biocartis' Evalution unit, which was …

    Published on 9/8/2014
  • Bristol-Myers, Merck, Ono Pharmaceutical cancer news

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Business: Cancer Bristol-Myers and Ono filed suit in the U…

    Published on 9/8/2014
  • Daiichi Sankyo pharmaceuticals news

    Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Business: Pharmaceuticals Daiichi will expand its Take a New Challenge for Drug Discovery (TaNeDS) collaborative drug discovery project to include all EU countries. The…

    Published on 9/8/2014
  • Depomed, Actavis neurology news

    Depomed Inc. (NASDAQ:DEPO), Menlo Park, Calif. Actavis plc (NYSE:ACT), Dublin, Ireland Business: Neurology Depomed said the U.S. District Court for the District of New Jersey ruled in favor of Depomed in a patent …

    Published on 9/8/2014
  • Eli Lilly, U.S. Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services diagnostic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. U.S. Centers for Medicare & Medicaid Services (CMS), Baltimore, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Diagnostic Eli Lilly is …

    Published on 9/8/2014
  • Galenica pharmaceuticals news

    Galenica Ltd. (SIX:GALN), Bern, Switzerland Business: Pharmaceuticals Galenica said David Ebsworth stepped down as CEO and that it is preparing its two business units -- its Vifor Pharma specialty pharma business and …

    Published on 9/8/2014
  • Mapp Biopharmaceutical, U.S. Department of Health and Human Services infectious news

    Mapp Biopharmaceutical Inc., San Diego, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded Mapp a $24.…

    Published on 9/8/2014
  • Novo Nordisk pharmaceuticals news

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Pharmaceuticals Novo Nordisk is discontinuing R&D within inflammatory disorders and will expand R&D in diabetes and obesity. The decision follows a …

    Published on 9/8/2014
  • Abbott, U.S. Department of Defense diagnostic news

    Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. U.S. Department of Defense, Washington, D.C. Business: Diagnostic Abbott received a $19.5 million contract from the DoD to assess and verify biomarkers of traumatic …

    Published on 9/1/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993